Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial (Q45178810)
Jump to navigation
Jump to search
scientific article published on 15 August 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial |
scientific article published on 15 August 2011 |
Statements
1 reference
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial (English)
1 reference
1 reference
1 reference
Giovanni Scambia
1 reference
Gabriella Ferrandina
1 reference
Antonella Savarese
1 reference
Roberto Sorio
1 reference
Enrico Breda
1 reference
Pietro Musso
1 reference
Luigi Frigerio
1 reference
Pietro Del Medico
1 reference
Alessandra Vernaglia Lombardi
1 reference
Antonio Febbraro
1 reference
Paolo Scollo
1 reference
Antonella Ferro
1 reference
Stefano Tamberi
1 reference
Alberto Ravaioli
1 reference
Maria Rosaria Valerio
1 reference
Enrico Aitini
1 reference
Donato Natale
1 reference
Laura Scaltriti
1 reference
Stefano Greggi
1 reference
Carmela Pisano
1 reference
Vanda Salutari
1 reference
Francesco Legge
1 reference
Ciro Gallo
1 reference
Francesco Perrone
1 reference
15 August 2011
1 reference
1 reference
29
1 reference
27
1 reference
3628-3635
1 reference
Identifiers
1 reference
1 reference